Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantationBruno Paiva, Jesús F. San Miguel, María‐Belén Vídriales et al.|Blood|2008Cited by 479
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myelomaJoaquín Martínez‐López, Ramón García‐Sánz, Albert Oriol et al.|Blood|2014Cited by 429
Long-term prognostic significance of response in multiple myeloma after stem cell transplantationJoaquín Martínez‐López, Joan Bladé, María‐Victoria Mateos et al.|Blood|2011Cited by 210
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myelomaCristina Pérez, Bruno Paiva, Cirino Botta et al.|Blood|2020Cited by 156
Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish RegistryAdrían Alegre, Jesús F. San Miguel, Rafael Martínez et al.|PubMed|2002Cited by 90